Peter Doran

Established Professor of Clinical Trials

University of Galway

Ireland

Research Interests

Explore related searches

Professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Doran is an Established Professor of Clinical Trials at the University of Galway, Ireland. His research focuses on clinical trials, particularly in the areas of chronic kidney disease, post-publication peer review, and ethical standards in COVID-19 studies. He has authored several recent articles addressing informed consent processes, SARS-CoV-2 variants, and innovative treatments for psoriasis, contributing to advancements in clinical research methodologies.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Tonny Veenith

University of Birmingham

UNITED KINGDOM

View details

Lai Ma

Assistant Professor

Dublin City University

IRELAND

View details

Cameron Knott

University of Melbourne

AUSTRALIA

View details

SILVIO GAROFALO

Associate Professor

University of Molise

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Doran

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.

An Overview of Post-Publication Peer Review

Adherence with reporting of ethical standards in COVID-19 human studies: a rapid review

An evaluation of the process of informed consent: views from research participants and staff

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conference

Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial

Time-related performance characteristics of high-sensitivity troponin I assay using manufacturer's controls and reagents

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled Trial

An investigation into the factors affecting investigator-initiated trial start-up in Ireland

Collaborators (4)

Tonny Veenith

Lai Ma

Cameron Knott

SILVIO GAROFALO

Make your next move.